4King GL,Ishii H,Koya D.Diabetic vascular dysfunctions：A model of excessive activation of protein kinase C 〔J〕.Kidney Int,1997,60：s77～s85.
5Giles TD,Ouyang J,Kerut EK,et al.Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB／Wor diabetic rat 〔J〕.Am J Physiol,1998,274：H295～H307.
6Donnelly R,Qu X.Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications〔J〕.Clin Exp Pharmacol Physiol,1998,25：79～87.
7Derubertis FR,Craven PA.Activation of protein kinase C in glomerular cells in diabetes：mechanisms and potential link to the pathogenesis of diabetic glomerulopathy 〔J〕.Diabetes,1994,43：1～8.
8Kunisaki M,Bursell SE,Umeda F,et al.Prevention of diabetes-induced abnormal retinal blood flow by treatment with d-alpha-tocopherol 〔J〕.Biofactors,1998,7：55～67.
9Xia P,Inoguchi T,Kern TS,et al.Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia 〔J〕.Diabetes,1994,43：1122～1129.
10Yasunare K,Kahno M,Kano H,et al.Possible involvement of phospholipase and protein kinase C in vascular growth induced by elevated glucose concentration 〔J〕.Hypertension,1996,28:159～168.
